Jingjing Chen
2Patents
1h-index
12Co-inventors
31Inventor score
Filing activity: Sep 16, 2016 → Dec 16, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11220541B2 | CCL20 as a predictor of clinical response to IL23-antagonists | Emerging Cross-Sectional Technologies | 1 | Active |
| US11016099B2 | Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.